Ottobock invests $5m in Blue Arbor for prosthetic control advancement
Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.
27 February 2026
27 February 2026
Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.